Magnesium aspartate dihydrate is indicated for the treatment and prevention of magnesium deficiency as diagnosed by a doctor. Magnaspartate is indicated in adults, children and adolescents aged from 2 years.
|NCPE Assessment Process||Complete|
|Rapid review commissioned||27/02/2019|
|Rapid review completed||14/05/2019|
|Rapid Review outcome||A full HTA is not recommended. The NCPE recommends that magnesium aspartate dihydrate not be considered for reimbursement at the submitted price. This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.|